Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Alliance for Clinical Trials in Oncology (1)

Merck Sharp & Dohme LLC (1)

Collaborator

Astellas Pharma US, Inc. (1)

National Cancer Institute (NCI) (1)

Intervention

enzalutamide (1)

pembrolizumab (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

salivary cancer

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

Recruiting

Advanced Cancer
+24 more

pembrolizumab

Los Angeles, California
+21 more

Jan 18, 2023

Salivary Cancer Trial in United States (enzalutamide)

Active, not recruiting

Salivary Cancer

enzalutamide

Anchorage, Alaska
+286 more

Oct 6, 2021